List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Ophtalmopharma Company

OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Their product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration (AMD).

Ophthalmopharma has granted Altacor exclusive rights for its two proprietary therapeutic products for the treatment of glaucoma and dry eye as well as exclusive rights for its EyeBar, a nutraceutical for the prevention of dry AMD and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery (currently known as SOLO).

Headquarters: Sarnen, Obwalden, Switzerland, Europe
Employee Number: 11-50
Industry: Drug Discovery & Development
Founded Date: 2003-01-01
Super Industry: Biopharma & Life Science Tools
Phone Number: +41 61 931 46 40
Investors: Armilar Venture Partners
Ipo Status: private
City: Sarnen
Region: Obwalden
Country: Switzerland